Date | Time | Source | Headline | Symbol | Company |
08/26/2024 | 2:03PM | iHub Newswire | FeaturedELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET | | |
05/14/2024 | 10:38AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:PAVMZ | PAVmed Inc |
05/13/2024 | 4:35PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:PAVMZ | PAVmed Inc |
05/07/2024 | 9:18AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:PAVMZ | PAVmed Inc |
01/17/2023 | 4:05PM | Business Wire | PAVmed and Lucid Diagnostics Provide Strategic Business Update | NASDAQ:PAVMZ | PAVmed Inc |
01/11/2023 | 8:00AM | Business Wire | PAVmed and Lucid Diagnostics to Provide Strategic Business Update | NASDAQ:PAVMZ | PAVmed Inc |
12/22/2022 | 8:25AM | Business Wire | PAVmed Partners with Novosound on Ultrasound Imaging Technology | NASDAQ:PAVMZ | PAVmed Inc |
12/15/2022 | 8:25AM | Business Wire | PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform | NASDAQ:PAVMZ | PAVmed Inc |
12/08/2022 | 8:25AM | Business Wire | Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry | NASDAQ:PAVMZ | PAVmed Inc |
12/01/2022 | 8:25AM | Business Wire | Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research | NASDAQ:PAVMZ | PAVmed Inc |
11/14/2022 | 4:40PM | Business Wire | Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results | NASDAQ:PAVMZ | PAVmed Inc |
11/11/2022 | 8:25AM | Business Wire | PAVmed to Participate in BTIG Digital Health Forum | NASDAQ:PAVMZ | PAVmed Inc |
11/10/2022 | 8:25AM | Business Wire | Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum | NASDAQ:PAVMZ | PAVmed Inc |
11/09/2022 | 8:25AM | Business Wire | Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer | NASDAQ:PAVMZ | PAVmed Inc |
11/03/2022 | 8:25AM | Business Wire | PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022 | NASDAQ:PAVMZ | PAVmed Inc |
11/02/2022 | 8:25AM | Business Wire | Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022 | NASDAQ:PAVMZ | PAVmed Inc |
08/30/2022 | 8:25AM | Business Wire | PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference | NASDAQ:PAVMZ | PAVmed Inc |
08/16/2022 | 4:40PM | Business Wire | PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results | NASDAQ:PAVMZ | PAVmed Inc |
08/11/2022 | 8:25AM | Business Wire | Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio | NASDAQ:PAVMZ | PAVmed Inc |
08/04/2022 | 8:25AM | Business Wire | Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies | NASDAQ:PAVMZ | PAVmed Inc |
07/19/2022 | 8:25AM | Business Wire | PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate America | NASDAQ:PAVMZ | PAVmed Inc |
07/18/2022 | 8:25AM | Business Wire | Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference | NASDAQ:PAVMZ | PAVmed Inc |
05/13/2022 | 8:25AM | Business Wire | PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO | NASDAQ:PAVMZ | PAVmed Inc |
04/28/2022 | 4:05PM | GlobeNewswire Inc. | PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action Lawsuit | NASDAQ:PAVMZ | PAVmed Inc |
04/26/2022 | 8:25AM | Business Wire | PAVmed to Hold a Business Update Conference Call on May 12, 2022 | NASDAQ:PAVMZ | PAVmed Inc |
03/29/2022 | 4:11PM | Business Wire | PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results | NASDAQ:PAVMZ | PAVmed Inc |
03/23/2022 | 8:25AM | Business Wire | PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers | NASDAQ:PAVMZ | PAVmed Inc |
03/17/2022 | 8:25AM | Business Wire | PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System | NASDAQ:PAVMZ | PAVmed Inc |
03/10/2022 | 8:25AM | Business Wire | PAVmed Subsidiary Veris Health Launches World-Class Technology Advisory Board | NASDAQ:PAVMZ | PAVmed Inc |
03/08/2022 | 8:30AM | Business Wire | PAVmed to Hold a Business Update Conference Call on March 29, 2022 | NASDAQ:PAVMZ | PAVmed Inc |